A detailed history of Westbourne Investment Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Westbourne Investment Advisors, Inc. holds 7,766 shares of ABT stock, worth $872,898. This represents 0.29% of its overall portfolio holdings.

Number of Shares
7,766
Previous 7,766 -0.0%
Holding current value
$872,898
Previous $883,000 8.61%
% of portfolio
0.29%
Previous 0.32%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

SELL
$95.06 - $111.52 $133,084 - $156,128
-1,400 Reduced 15.27%
7,766 $853,000
Q3 2022

Nov 02, 2022

BUY
$96.76 - $112.03 $886,902 - $1.03 Million
9,166 New
9,166 $887,000
Q2 2022

Aug 04, 2022

SELL
$102.07 - $123.37 $996,815 - $1.2 Million
-9,766 Closed
0 $0
Q2 2021

Aug 02, 2021

SELL
$105.79 - $124.53 $10,579 - $12,453
-100 Reduced 1.01%
9,766 $1.13 Million
Q3 2020

Nov 03, 2020

SELL
$91.64 - $111.29 $21,077 - $25,596
-230 Reduced 2.28%
9,866 $1.07 Million
Q2 2020

Jul 14, 2020

SELL
$76.57 - $98.0 $58,576 - $74,970
-765 Reduced 7.04%
10,096 $923,000
Q1 2020

Apr 21, 2020

SELL
$62.82 - $91.86 $6,282 - $9,186
-100 Reduced 0.91%
10,861 $857,000
Q4 2019

Jan 23, 2020

SELL
$78.51 - $87.4 $37,998 - $42,301
-484 Reduced 4.23%
10,961 $952,000
Q3 2019

Oct 22, 2019

SELL
$81.84 - $88.74 $81,840 - $88,740
-1,000 Reduced 8.04%
11,445 $958,000
Q1 2019

Apr 15, 2019

SELL
$66.22 - $80.06 $8,939 - $10,808
-135 Reduced 1.07%
12,445 $995,000
Q3 2018

Oct 18, 2018

BUY
$60.81 - $73.36 $182,430 - $220,080
3,000 Added 31.32%
12,580 $923,000
Q2 2018

Aug 07, 2018

SELL
$57.57 - $63.54 $17,271 - $19,062
-300 Reduced 3.04%
9,580 $584,000
Q4 2017

Jan 31, 2018

SELL
$53.68 - $57.47 $2,684 - $2,873
-50 Reduced 0.5%
9,880 $564,000
Q3 2017

Oct 23, 2017

BUY
$48.06 - $53.64 $477,235 - $532,645
9,930
9,930 $530,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Westbourne Investment Advisors, Inc. Portfolio

Follow Westbourne Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westbourne Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westbourne Investment Advisors, Inc. with notifications on news.